Cargando…
A Panel of Urinary Volatile Biomarkers for Differential Diagnosis of Prostate Cancer from Other Urological Cancers
Our group recently developed a urinary 6-biomarker panel for the diagnosis of prostate cancer (PCa) which has a higher level of accuracy compared to the serum prostate specific antigen (PSA) test. Herein, urine from an independent cohort of PCa patients and cancer-free controls was analyzed to furth...
Autores principales: | Lima, Ana Rita, Pinto, Joana, Carvalho-Maia, Carina, Jerónimo, Carmen, Henrique, Rui, Bastos, Maria de Lourdes, Carvalho, Márcia, Guedes de Pinho, Paula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464354/ https://www.ncbi.nlm.nih.gov/pubmed/32717987 http://dx.doi.org/10.3390/cancers12082017 |
Ejemplares similares
-
Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine
por: Lima, Ana Rita, et al.
Publicado: (2019) -
Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging through Urine Metabolomics
por: Pinto, Joana, et al.
Publicado: (2021) -
Pharmacometabolomics Applied to Personalized Medicine in Urological Cancers
por: Amaro, Filipa, et al.
Publicado: (2022) -
Discrimination between the human prostate normal and cancer cell exometabolome by GC-MS
por: Lima, Ana Rita, et al.
Publicado: (2018) -
GC-MS-Based Endometabolome Analysis Differentiates Prostate Cancer from Normal Prostate Cells
por: Lima, Ana Rita, et al.
Publicado: (2018)